Latest Ratios: P/E Ratio -142.7x · EV/EBITDA 20.2x · ROE -1.7%. (2006–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $7.4B | $7.9B | $4.1B | $3.2B | $2.9B | $4.9B | $3.7B | $3.6B | $2.3B | $3.5B | $2.6B |
| Enterprise Value | $9.0B | $9.6B | $4.1B | $3.4B | $3.8B | $5.5B | $4.1B | $4.3B | $2.7B | $3.9B | $3.0B |
| P/E Ratio → | -142.70 | — | 47.96 | 5.49 | 22.44 | 41.62 | 33.59 | 28.02 | 22.23 | 43.79 | 37.86 |
| P/S Ratio | 1.94 | 2.07 | 2.38 | 1.92 | 1.84 | 3.52 | 2.12 | 1.85 | 1.20 | 2.16 | 1.90 |
| P/B Ratio | 1.66 | 1.77 | 2.65 | 2.14 | 3.24 | 6.57 | 5.74 | 6.33 | 5.06 | 8.00 | 14.24 |
| P/FCF | 30.88 | 33.10 | 20.91 | — | 50.81 | 28.64 | 16.79 | 49.86 | 20.27 | 52.99 | 84.53 |
| P/OCF | 21.52 | 23.06 | 17.52 | 80.61 | 20.60 | 22.03 | 14.50 | 32.71 | 15.02 | 33.79 | 38.00 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.52 | 2.40 | 2.02 | 2.41 | 3.94 | 2.39 | 2.19 | 1.38 | 2.38 | 2.24 |
| EV / EBITDA | 20.18 | 21.35 | 19.81 | 13.11 | 18.38 | 27.95 | 17.59 | 16.80 | 13.19 | 19.87 | 21.70 |
| EV / EBIT | 47.77 | 225.30 | 35.86 | 18.91 | 28.16 | 42.27 | 25.93 | 22.97 | 18.59 | 26.64 | 29.27 |
| EV / FCF | — | 40.22 | 21.03 | — | 66.51 | 32.10 | 18.98 | 58.99 | 23.29 | 58.23 | 99.89 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 35.1% | 35.1% | 36.5% | 35.2% | 33.3% | 34.4% | 30.9% | 30.7% | 28.0% | 28.8% | 28.2% |
| Operating Margin | 5.0% | 5.0% | 6.9% | 9.9% | 8.3% | 9.0% | 9.4% | 9.7% | 7.5% | 8.8% | 7.5% |
| Net Profit Margin | -1.3% | -1.3% | 5.0% | 35.0% | 8.6% | 8.5% | 6.3% | 6.6% | 5.4% | 4.9% | 5.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -1.7% | -1.7% | 5.6% | 48.7% | 16.6% | 17.2% | 18.0% | 25.1% | 23.2% | 25.9% | 43.7% |
| ROA | -0.9% | -0.9% | 2.8% | 21.8% | 5.7% | 6.0% | 5.8% | 7.7% | 7.3% | 6.2% | 6.6% |
| ROIC | 3.7% | 3.7% | 5.5% | 7.1% | 6.3% | 7.7% | 10.4% | 13.9% | 13.5% | 15.0% | 14.8% |
| ROCE | 4.0% | 4.0% | 4.6% | 7.8% | 7.3% | 8.5% | 11.7% | 15.7% | 15.1% | 16.5% | 15.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.42 | 0.42 | 0.81 | 0.43 | 1.08 | 0.90 | 0.82 | 1.23 | 0.85 | 0.87 | 2.77 |
| Debt / EBITDA | 4.20 | 4.20 | 6.03 | 2.52 | 4.68 | 3.41 | 2.23 | 2.75 | 1.92 | 1.96 | 3.57 |
| Net Debt / Equity | — | 0.38 | 0.02 | 0.11 | 1.00 | 0.79 | 0.75 | 1.16 | 0.75 | 0.79 | 2.59 |
| Net Debt / EBITDA | 3.78 | 3.78 | 0.11 | 0.64 | 4.34 | 3.01 | 2.03 | 2.60 | 1.71 | 1.79 | 3.34 |
| Debt / FCF | — | 7.12 | 0.12 | — | 15.71 | 3.46 | 2.19 | 9.12 | 3.02 | 5.24 | 15.36 |
| Interest Coverage | 0.40 | 0.40 | 5.92 | 7.30 | 8.36 | 11.67 | 11.47 | 9.88 | 10.28 | 10.72 | 11.00 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.98 | 0.98 | 3.48 | 2.27 | 1.48 | 1.31 | 1.35 | 1.49 | 1.27 | 1.33 | 1.23 |
| Quick Ratio | 0.58 | 0.58 | 3.04 | 1.78 | 1.06 | 0.89 | 0.92 | 0.98 | 0.85 | 0.90 | 0.88 |
| Cash Ratio | 0.11 | 0.11 | 2.29 | 1.00 | 0.11 | 0.14 | 0.10 | 0.08 | 0.09 | 0.08 | 0.08 |
| Asset Turnover | — | 0.46 | 0.50 | 0.61 | 0.60 | 0.65 | 0.96 | 1.02 | 1.33 | 1.18 | 1.14 |
| Inventory Turnover | 3.83 | 3.83 | 4.67 | 4.52 | 4.02 | 4.01 | 6.05 | 5.50 | 6.71 | 6.12 | 6.95 |
| Days Sales Outstanding | — | 53.95 | 71.28 | 63.36 | 60.96 | 86.90 | 64.30 | 68.15 | 61.55 | 70.63 | 70.41 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.3% | 0.3% | 0.3% | 0.4% | 0.4% | 0.3% | 0.4% | 0.4% | 0.6% | 0.4% | 0.5% |
| Payout Ratio | — | — | 15.3% | 2.2% | 9.5% | 10.7% | 11.8% | 9.8% | 12.6% | 15.8% | 17.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 2.1% | 18.2% | 4.5% | 2.4% | 3.0% | 3.6% | 4.5% | 2.3% | 2.6% |
| FCF Yield | 3.2% | 3.0% | 4.8% | — | 2.0% | 3.5% | 6.0% | 2.0% | 4.9% | 1.9% | 1.2% |
| Buyback Yield | 0.0% | 0.0% | 0.1% | 0.2% | 0.3% | 0.0% | 0.0% | 0.0% | 0.9% | 0.1% | 0.2% |
| Total Shareholder Yield | 0.3% | 0.3% | 0.4% | 0.6% | 0.7% | 0.3% | 0.4% | 0.4% | 1.4% | 0.5% | 0.6% |
| Shares Outstanding | — | $52M | $32M | $32M | $32M | $32M | $32M | $32M | $32M | $32M | $30M |
Marel integration execution risk
According to recent market data, JBTM trades at a forward P/E of 16.82, suggesting that investors are pricing in a recovery in earnings power as the company transitions from a period of heavy M&A-related accounting distortions to a more normalized operational state post-Marel acquisition.
The negative TTM P/E ratio is a clear artifact of non-cash acquisition costs rather than a reflection of structural business failure. Investors should monitor whether the forward multiple remains compressed, as this would indicate skepticism regarding the company's ability to achieve the projected synergies required to justify its current valuation.
Based on reported figures, JBTM's ROIC has compressed to 0.8% in 2026Q1, a significant decline from historical levels, which highlights the immediate dilutive impact of the Marel acquisition on the company's ability to generate returns on its expanded invested capital base.
The current low return on capital is typical for large-scale industrial mergers where the asset base grows faster than the immediate earnings contribution. The path to restoring ROIC will depend on management's ability to optimize the combined manufacturing footprint and reduce the heavy amortization burden currently weighing on the denominator.
As reported in financial statements, the cash conversion cycle reached 111 days in 2026Q1, reflecting the operational friction of integrating disparate supply chains and inventory management systems across the newly combined global food technology entity following the Marel merger.
The elevated days inventory outstanding (DIO) of 97 days suggests that the company is currently carrying significant buffer stock, likely to mitigate supply chain risks during the integration phase. A sustained reduction in this cycle is necessary to demonstrate that the combined entity is achieving the intended operational efficiencies.
According to recent SEC filings, JBTM's interest coverage ratio of 6.80x in 2026Q1 indicates a moderate level of comfort, yet the debt-to-EBITDA ratio of 13.55x remains elevated, signaling that the company's leverage profile is currently strained by the financing costs of its recent expansion.
While the interest coverage appears manageable, the high debt-to-EBITDA ratio warrants close monitoring, as it leaves little room for error if the integration process faces further delays. Investors should look for a consistent downward trend in this ratio as the company begins to deleverage through improved cash flow generation.
Based on the provided data, the most commonly misapplied metric for JBTM is the GAAP net margin, which currently sits at -1.33% and obscures the underlying operational health of the business by including significant non-cash amortization and one-time integration expenses related to the Marel merger.
Analysts should instead focus on adjusted EBITDA margins or free cash flow conversion to gauge the true earning power of the combined entity. Relying on GAAP net income in this context risks misinterpreting a temporary accounting reality as a permanent deterioration in the company's competitive or operational standing.
Includes 30+ ratios · 20 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying JBTM stock.
JBT Marel Corporation's current P/E ratio is -142.7x. The historical average is 25.5x.
JBT Marel Corporation's current EV/EBITDA is 20.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 14.7x.
JBT Marel Corporation's return on equity (ROE) is -1.7%. The historical average is 32.0%.
Based on historical data, JBT Marel Corporation is trading at a P/E of -142.7x. Compare with industry peers and growth rates for a complete picture.
JBT Marel Corporation's current dividend yield is 0.28%.
JBT Marel Corporation has 35.1% gross margin and 5.0% operating margin.
JBT Marel Corporation's Debt/EBITDA ratio is 4.2x, indicating high leverage. A ratio above 4x may signal elevated financial risk.